"Lipid Metabolism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS.
Descriptor ID |
D050356
|
MeSH Number(s) |
G03.458
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lipid Metabolism".
Below are MeSH descriptors whose meaning is more specific than "Lipid Metabolism".
This graph shows the total number of publications written about "Lipid Metabolism" by people in this website by year, and whether "Lipid Metabolism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
2001 | 1 | 1 | 2 |
2004 | 0 | 1 | 1 |
2006 | 1 | 1 | 2 |
2007 | 1 | 0 | 1 |
2010 | 0 | 2 | 2 |
2012 | 0 | 1 | 1 |
2013 | 1 | 1 | 2 |
2014 | 1 | 1 | 2 |
2019 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipid Metabolism" by people in Profiles.
-
MicroRNA Let-7 targets AMPK and impairs hepatic lipid metabolism in offspring of maternal obese pregnancies. Sci Rep. 2021 04 26; 11(1):8980.
-
Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice. Clin Sci (Lond). 2019 11 15; 133(21):2189-2202.
-
Reply: To PMID 23996730. Hepatology. 2014 Sep; 60(3):1114-5.
-
Follistatin promotes adipocyte differentiation, browning, and energy metabolism. J Lipid Res. 2014 Mar; 55(3):375-84.
-
Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology. 2014 Feb; 59(2):483-95.
-
Inhibition of in vitro and in vivo brown fat differentiation program by myostatin. Obesity (Silver Spring). 2013 Jun; 21(6):1180-8.
-
Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. Exp Mol Pathol. 2012 Aug; 93(1):26-34.
-
Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression. FASEB J. 2011 Apr; 25(4):1133-44.
-
Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010 Jul; 139(1):323-34.e7.
-
Gender-specific programmed hepatic lipid dysregulation in intrauterine growth-restricted offspring. Am J Obstet Gynecol. 2007 May; 196(5):477.e1-7.